
Subject to intense pressure over the last few days, Mylan has made an attempt to avoid becoming “another Valeant” by …

The US congress is again subjecting the pharmaceutical industry to heavy scrutiny over drug pricing policies with Mylan its latest …
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions

